Margaret Hamburg
Showing 1–3 of 3 transcripts.
- Milken Institute1h 2m
Outsmarting Superbugs: What Are the Alternatives?
Margaret Hamburg, Matthew Hepburn, Peter Jackson, Nancy Knight, Jeanette Mucha, Peter Piot, Peggy Hamburg, David Wallace, Lance Price
Global leaders and organizations including the WHO, CDC, and the U.K. government are coordinating a multi-faceted response to antimicrobial resistance, which threatens to cause 10 million annual deaths by 2050 and mimic the 2008 financial crisis through massive economic losses. Innovative initiatives such as the CDC's AMR Challenge, Carb-X's $80 million funding for 40 development projects, and the U.K.'s "pull incentive" trial aim to revitalize the antibiotic pipeline by supporting SMEs and rewarding disease prevention rather than sales volume. Despite these advances, experts warn that rigid intellectual property laws, inadequate wastewater treatment, and capital gaps in microbiome startups hinder the deployment of new therapies needed to combat untreatable superbugs like drug-resistant tuberculosis.
- Milken Institute1h 1m
Creating a Culture of Biomedical Innovation
Mike Rea, Christopher Austin, Amitabh Chandra, Margaret Hamburg, Jennifer Miller, Jason Spangler
A cross-sector panel comprising leaders from NCATS, the FDA, Harvard, and Amgen redefined biomedical innovation as a value-driven process that balances patient outcomes with accessibility and ethical trust. By advocating for a collaborative culture that normalizes failure and breaks down silos between research, regulation, and reimbursement, the group proposed shifting metrics from simple speed to societal acceleration and integrity. The discussion ultimately highlighted critical misalignments in R&D funding, noting that commercial incentives currently neglect major disease burdens like mental health and neglected tropical diseases, necessitating a structural shift toward public-sector leadership.
- Milken Institute1h 4m
Enterprising Families at the Forefront of Business in Mexico
Cate Ambrose, Alonso Díaz Etienne, Gina Diez Barroso, Nicolás Mariscal Servitje, Margaret Hamburg, Margot Santos
The Latin American Private Capital Association (LAFCA) highlighted a demographic and institutional shift in Mexico's economy, where a young, US-educated generation is driving family offices and corporations like Grupo Bimbo and Hebera Capital to expand globally while prioritizing governance and sustainability. Panelists detailed strategies from Grupo Dyarik's educational reforms in Mexico City and Miami to Grupo Marños' infrastructure ethics, illustrating how these entities are leveraging local talent to counterbalance market uncertainty ahead of the 2018 presidential election. Despite rhetoric regarding US-Mexico relations, business leaders emphasized robust checks and balances and a surge in private pension fund participation, positioning Mexico as a stable, competitive hub for energy, infrastructure, and technology investment.